Bio-Rad Laboratories Pioneer Antibody Discovery Platform SpyLock service

Bio-Rad Laboratories has expanded its Pioneer Antibody Discovery Platform services with the addition of fast generation and screening of bispecific antibodies, based on the company’s proprietary SpyLock Technology. The SpyLock service builds upon the capabilities of the Pioneer Platform, enabling users to rapidly generate and screen bispecific antibodies to identify effective antibody combinations to take forward into development.

The platform features a fully human synthetic phage display library engineered to include more than 200 billion unique sequences and to be capable of identifying high-affinity antibody candidates using Bio-Rad’s SpyDisplay selection technology. With proprietary TrailBlazer technology, it provides prototypes of therapeutic antibodies in a multitude of formats for streamlined lead identification.

The final antibodies are fully mammalian expressed IgGs, functionally characterised with a complete data package and sequence. The platform is paired with a high-quality and comprehensive suite of discovery services that can be customised to meet a project’s needs.